These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 11858856)

  • 21. Evidence that high potency foot-and-mouth disease vaccine inhibits local virus replication and prevents the "carrier" state in sheep.
    Barnett PV; Keel P; Reid S; Armstrong RM; Statham RJ; Voyce C; Aggarwal N; Cox SJ
    Vaccine; 2004 Mar; 22(9-10):1221-32. PubMed ID: 15003651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of novel inactivated vaccines for the SAT 1, SAT 2 and SAT 3 serotypes of foot-and-mouth disease in pigs.
    Jo HE; You SH; Choi JH; Ko MK; Shin SH; Song J; Jo H; Lee MJ; Kim SM; Kim B; Park JH
    Virol J; 2019 Dec; 16(1):156. PubMed ID: 31842907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficient protection against Asia1 type foot-and-mouth disease using a chimeric vaccine strain suitable for East Asia.
    Ko MK; Jo HE; Choi JH; You SH; Shin SH; Hwang SY; Jo H; Kim HM; Lee MJ; Kim SM; Kim B; Park JH
    Vet Microbiol; 2021 Feb; 253():108975. PubMed ID: 33418393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiating infection from vaccination in foot-and-mouth-disease: evaluation of an ELISA based on recombinant 3ABC.
    Bruderer U; Swam H; Haas B; Visser N; Brocchi E; Grazioli S; Esterhuysen JJ; Vosloo W; Forsyth M; Aggarwal N; Cox S; Armstrong R; Anderson J
    Vet Microbiol; 2004 Jul; 101(3):187-97. PubMed ID: 15223123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Foot-and-Mouth Disease Carrier State Divergence in Cattle.
    Stenfeldt C; Eschbaumer M; Rekant SI; Pacheco JM; Smoliga GR; Hartwig EJ; Rodriguez LL; Arzt J
    J Virol; 2016 Jul; 90(14):6344-64. PubMed ID: 27147736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Importance of foot and mouth disease vaccine purity in interpreting serological surveys.
    Smitsaart E; Espinoza AM; Maradei E; Cosentino B; Guinzburg M; Madonni G; Cadenazzi G; Bottini R; Filippi J; Bergmann I
    Rev Sci Tech; 2015 Dec; 34(3):755-66, 741-54. PubMed ID: 27044149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic Foot-and-Mouth Disease Vaccination in Cattle Promotes Specific Antibody-Secreting Cells at the Respiratory Tract and Triggers Local Anamnestic Responses upon Aerosol Infection.
    Pega J; Di Giacomo S; Bucafusco D; Schammas JM; Malacari D; Barrionuevo F; Capozzo AV; Rodríguez LL; Borca MV; Pérez-Filgueira M
    J Virol; 2015 Sep; 89(18):9581-90. PubMed ID: 26157128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current situation and future preventive measures of foot-and-mouth disease in Japan].
    Akashi H
    Uirusu; 2010 Dec; 60(2):249-55. PubMed ID: 21488337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospects, including time-frames, for improved foot and mouth disease vaccines.
    Grubman MJ; Mason PW
    Rev Sci Tech; 2002 Dec; 21(3):589-600. PubMed ID: 12523699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benefit-cost analysis of vaccination and preemptive slaughter as a means of eradicating foot-and-mouth disease.
    Bates TW; Carpenter TE; Thurmond MC
    Am J Vet Res; 2003 Jul; 64(7):805-12. PubMed ID: 12856762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Needleless intradermal vaccination for foot-and-mouth disease induced granuloma-free effective protection in pigs.
    Hwang JH; Lee KN; Kim SM; Lee G; Moon Y; Kim B; Lee JS; Park JH
    J Vet Sci; 2019 May; 20(3):e29. PubMed ID: 31161747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with a FMDV O Mya98 lineage virus in pigs 4 and 7 days post vaccination.
    Wilna V; Hong NT; Geoffrey FT; Jacqueline MM; Jianning W; Van Phuc K; Ngon QV; Phuong le TT; Hung D; Hanh TX; Van Hung V; Anh le TQ; Tien MT; Quang le TV; Long NT; Nagendrakumar SB
    Vaccine; 2015 Jun; 33(24):2778-85. PubMed ID: 25917677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination of cattle only is sufficient to stop FMDV transmission in mixed populations of sheep and cattle.
    Bravo DE Rueda C; Dekker A; Eblé PL; DE Jong MC
    Epidemiol Infect; 2015 Aug; 143(11):2279-86. PubMed ID: 25464822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune responses in pigs and cattle vaccinated with half-volume foot-and-mouth disease vaccine.
    Park ME; You SH; Lee SY; Lee KN; Ko MK; Choi JH; Kim B; Lee JS; Park JH
    J Vet Sci; 2017 Aug; 18(S1):323-331. PubMed ID: 28859272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of ENABL® adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine.
    Barrera J; Schutta C; Pisano M; Grubman MJ; Brake DA; Miller T; Kamicker BJ; Olutunmbi F; Ettyreddy D; Brough DE; Butman BT; Neilan JG
    Vaccine; 2018 Feb; 36(8):1078-1084. PubMed ID: 29358056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined administration of synthetic RNA and a conventional vaccine improves immune responses and protection against foot-and-mouth disease virus in swine.
    Borrego B; Blanco E; Rodríguez Pulido M; Mateos F; Lorenzo G; Cardillo S; Smitsaart E; Sobrino F; Sáiz M
    Antiviral Res; 2017 Jun; 142():30-36. PubMed ID: 28315707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of vaccination on undetected persistence of foot-and-mouth disease virus in cattle herds and sheep flocks.
    Schley D; Paton DJ; Cox SJ; Parida S; Gubbins S
    Epidemiol Infect; 2009 Oct; 137(10):1494-504. PubMed ID: 19288960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Further evaluation of higher potency vaccines for early protection of cattle against FMDV direct contact challenge.
    Cox SJ; Parida S; Voyce C; Reid SM; Hamblin PA; Hutchings G; Paton DJ; Barnett PV
    Vaccine; 2007 Nov; 25(44):7687-95. PubMed ID: 17913309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Control and eradication of foot-and-mouth disease.
    Sutmoller P; Barteling SS; Olascoaga RC; Sumption KJ
    Virus Res; 2003 Jan; 91(1):101-44. PubMed ID: 12527440
    [No Abstract]   [Full Text] [Related]  

  • 40. A Malaysia 97 monovalent foot-and-mouth disease vaccine (>6PD50/dose) protects pigs against challenge with a variant FMDV A SEA-97 lineage virus, 4 and 7 days post vaccination.
    Nagendrakumar SB; Hong NT; Geoffrey FT; Jacqueline MM; Andrew D; Michelle G; Van Phuc K; Ngon QV; Phuong le TT; Phuc NN; Hanh TX; Van Hung V; Quynhanh le T; Tan TM; Long NT; Wilna V
    Vaccine; 2015 Aug; 33(36):4513-9. PubMed ID: 26192355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.